162 related articles for article (PubMed ID: 33828015)
1. [Intravenous immunoglobulin in combination with ibrutinib for the treatment of IgM-type M protein associated peripheral neuropathy complicated with chronic lymphocytic leukemia].
Sakata M; Saburi M; Kawano K; Takata H; Miyazaki Y; Uchida H; Kawano Y; Ohtsuka E
Rinsho Ketsueki; 2021; 62(3):196-199. PubMed ID: 33828015
[TBL] [Abstract][Full Text] [Related]
2. Pure red cell aplasia occurring during ibrutinib therapy for chronic lymphocytic leukemia.
Wang L; Wu S; Yu G; Sui X; Chu X; Liu X
J Oncol Pharm Pract; 2023 Dec; 29(8):2031-2036. PubMed ID: 37518980
[TBL] [Abstract][Full Text] [Related]
3. Demyelinating neuropathy due to primary IgM kappa B cell lymphoma of peripheral nerve.
Ince PG; Shaw PJ; Fawcett PR; Bates D
Neurology; 1987 Jul; 37(7):1231-5. PubMed ID: 3037440
[TBL] [Abstract][Full Text] [Related]
4. Central nervous system expression of a monoclonal paraprotein in a chronic lymphocytic leukemia patient.
Ruiz P; Moezzi M; Chamizo W; Ganjei P; Whitcomb CC; Rey LC
Acta Haematol; 1992; 88(1):37-40. PubMed ID: 1414160
[TBL] [Abstract][Full Text] [Related]
5. [Improvement of autoimmune cytopenia with ibrutinib in a chronic lymphocytic leukemia patient complicated by monoclonal immunoglobulin deposition disease].
Nakamura M; Yoshioka S; Yamashita D; Hara S; Ishikawa T
Rinsho Ketsueki; 2019; 60(10):1449-1454. PubMed ID: 31695006
[TBL] [Abstract][Full Text] [Related]
6. Obinutuzumab, a new anti-CD20 antibody, and chlorambucil are active and effective in anti-myelin-associated glycoprotein antibody polyneuropathy.
Briani C; Visentin A; Salvalaggio A; Cacciavillani M; Trentin L
Eur J Neurol; 2019 Feb; 26(2):371-375. PubMed ID: 30315672
[TBL] [Abstract][Full Text] [Related]
7. Sensorimotor polyneuropathy associated with chronic lymphocytic leukemia, IgM antigangliosides antibody and human T-cell leukemia virus I infection.
Mitsui Y; Kusunoki S; Hiruma S; Akamatsu M; Kihara M; Hashimoto S; Takahashi M
Muscle Nerve; 1999 Oct; 22(10):1461-5. PubMed ID: 10487916
[TBL] [Abstract][Full Text] [Related]
8. Complete resolution of chylothorax with ibrutinib in chronic lymphocytic leukemia: a case report.
Cheng L; Huang M; Wei J; Xu H; Zhou M; Jiang L
Ann Palliat Med; 2022 May; 11(5):1833-1837. PubMed ID: 34328006
[TBL] [Abstract][Full Text] [Related]
9. Ublituximab plus ibrutinib versus ibrutinib alone for patients with relapsed or refractory high-risk chronic lymphocytic leukaemia (GENUINE): a phase 3, multicentre, open-label, randomised trial.
Sharman JP; Brander DM; Mato AR; Ghosh N; Schuster SJ; Kambhampati S; Burke JM; Lansigan F; Schreeder MT; Lunin SD; Zweibach A; Shtivelband M; Travis PM; Chandler JC; Kolibaba KS; Sportelli P; Miskin HP; Weiss MS; Flinn IW
Lancet Haematol; 2021 Apr; 8(4):e254-e266. PubMed ID: 33631112
[TBL] [Abstract][Full Text] [Related]
10. High surface IgM levels associate with shorter response to ibrutinib and BTK bypass in patients with CLL.
Chiodin G; Drennan S; Martino EA; Ondrisova L; Henderson I; Del Rio L; Tracy I; D'Avola A; Parker H; Bonfiglio S; Scarfò L; Sutton LA; Strefford JC; Forster J; Brake O; Potter KN; Sale B; Lanham S; Mraz M; Ghia P; Stevenson FK; Forconi F
Blood Adv; 2022 Sep; 6(18):5494-5504. PubMed ID: 35640238
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
Lunn MP; Nobile-Orazio E
Cochrane Database Syst Rev; 2012 May; (5):CD002827. PubMed ID: 22592686
[TBL] [Abstract][Full Text] [Related]
12. Destabilization of ROR1 enhances activity of Ibrutinib against chronic lymphocytic leukemia in vivo.
Liu Z; Liu J; Zhang T; Shi M; Chen X; Chen Y; Yu J
Pharmacol Res; 2020 Jan; 151():104512. PubMed ID: 31726100
[TBL] [Abstract][Full Text] [Related]
13. [Anti-myelin-associated glycoprotein antibody positive IgM monoclonal gammopathy related peripheral neuropathy: 11 cases and literature review].
Gao XM; Jia MN; Qian M; Ren HT; Zhang L; Shen KN; Cao XX; Li J
Zhonghua Xue Ye Xue Za Zhi; 2019 Nov; 40(11):901-905. PubMed ID: 31856437
[No Abstract] [Full Text] [Related]
14. A randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. The IgM-associated Polyneuropathy Study Group.
Mariette X; Chastang C; Clavelou P; Louboutin JP; Leger JM; Brouet JC
J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):28-34. PubMed ID: 9221964
[TBL] [Abstract][Full Text] [Related]
15. ALK-positive histiocytosis associated with chronic lymphocytic leukaemia/small lymphocytic lymphoma: a multitarget response under ibrutinib.
Syrykh C; Ysebaert L; Péricart S; Evrard SM; Meggetto F; Kanoun S; Brousset P; Laurent C
Virchows Arch; 2021 Apr; 478(4):779-783. PubMed ID: 33011863
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory effects of different intravenous immunoglobulin preparations in chronic lymphocytic leukemia.
Colado A; Elías EE; Sarapura Martínez VJ; Cordini G; Morande P; Bezares F; Giordano M; Gamberale R; Borge M
Sci Rep; 2021 Jun; 11(1):12926. PubMed ID: 34155276
[TBL] [Abstract][Full Text] [Related]
17. Optic Neuropathy Due to Chronic Lymphocytic Leukemia Proven With Optic Nerve Sheath Biopsy.
Khan K; Malik AI; Almarzouqi SJ; Morgan ML; Yalamanchili S; Chevez-Barrios P; Lee AG
J Neuroophthalmol; 2016 Mar; 36(1):61-6. PubMed ID: 26436987
[TBL] [Abstract][Full Text] [Related]
18. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J
Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994
[TBL] [Abstract][Full Text] [Related]
19. Ibrutinib-Associated Leukocytoclastic Vasculitis in a Patient with Chronic Lymphocytic Leukemia.
Kaya A; Aras İ; Özkan Kurtgöz P; Çakıroğlu U
Turk J Haematol; 2024 Mar; 41(1):57-58. PubMed ID: 38433497
[No Abstract] [Full Text] [Related]
20. Ibrutinib-Induced Cardiac Tamponade in Chronic Lymphocytic Leukemia.
Kidoguchi K; Kubato Y; Nishimura Y; Kizuka-Sano H; Kimura S
Turk J Haematol; 2021 Feb; 38(1):83-85. PubMed ID: 33161683
[No Abstract] [Full Text] [Related]
[Next] [New Search]
